Re: randomised prostate cancer screening trial: 20 year follow-up.

摘要

Prostate cancer (PCa) screening continues to generate controversy. Both the European Randomized Study of Prostate Cancer Screening and the Goteborg randomized screening trial reported significant reductions in PCa-specific mortality with prostate-specific antigen (PSA)-based screening [1,2], whereas the US Prostate, Lung, Colorectal and Ovary cancer-screening trial reported no mortality difference between men randomized to screening compared with controls [3].